Connection
Robert Kramer to Methyl Parathion
This is a "connection" page, showing publications Robert Kramer has written about Methyl Parathion.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.055 |
|
|
|
-
Kyle PB, Smith SV, Baker RC, Kramer RE. Mass spectrometric detection of CYP450 adducts following oxidative desulfuration of methyl parathion. J Appl Toxicol. 2013 Jul; 33(7):644-51.
Score: 0.379
-
Kramer RE, Wellman SE, Rockhold RW, Baker RC. Pharmacokinetics of methyl parathion: a comparison following single intravenous, oral or dermal administration. J Biomed Sci. 2002 Jul-Aug; 9(4):311-20.
Score: 0.195
-
Kramer RE, Ho IK. Pharmacokinetics and pharmacodynamics of methyl parathion. Zhonghua Yi Xue Za Zhi (Taipei). 2002 May; 65(5):187-99.
Score: 0.193
-
Kramer RE, Wellman SE, Zhu H, Rockhold RW, Baker RC. A comparison of cholinesterase activity after intravenous, oral or dermal administration of methyl parathion. J Biomed Sci. 2002 Mar-Apr; 9(2):140-8.
Score: 0.191
-
Ma T, Kramer RE, Baker RC, Fan LW, Ho IK. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats. J Neurosci Res. 2003 Jan 01; 71(1):138-45.
Score: 0.051
-
Zhu H, Rockhold RW, Baker RC, Kramer RE, Ho IK. Effects of single or repeated dermal exposure to methyl parathion on behavior and blood cholinesterase activity in rats. J Biomed Sci. 2001 Nov-Dec; 8(6):467-74.
Score: 0.047